Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Herlev and Gentofte Hospital
With
University of Copenhagen
Age
65–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Participants must:
Be operated for primary breast cancer within 12 weeks or
Be diagnosed with locally advanced or metastatic breast cancer. Be treated with (neo)adjuvant or first or second-line palliative therapy defined as chemotherapy ± HER2 directed treatment, ± antihormonal treatment, antihormonal treatment ± HER 2, directed treatment ± CDK 4/6 inhibitor.
Be ≥ 65 years of age at the time of signing the informed consent form
Have an Eastern Cooperative Oncology Group (ECOG) performance status score ≤ 2
Be able to speak and read Danish, and to provide a signed informed consent form.
You may not be if
Participants with:
Any physical condition that hinder the execution of physical exercise training
Other types of cancer
Documented and uncontrolled brain metastases that hinder participation in an exercise-based trial, based on the referring oncologist's assessment
Dementia, psychotic disorders, or other cognitive diseases or conditions that hinder written consent
Unstable medical disease or history of serious or concurrent illness; any medical condition that might be aggravated by exercise training or that cannot be controlled, including, but not restricted congestive heart failure (NYHA class III-IV), unstable angina pectoris, implantable cardioverter defibrillator (ICD), or myocardial infarction within 6 months, based on the referring oncologist's assessment.
In patients with documented bone metastases:
\- A bone metastatic burden or location that poses a risk of injury in the performance of exercise training, as assessed by the referring oncologist.
Clareo Health | Exercise in Older Women With Breast Cancer During Systemic Therapy
